AQR Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.99M | Buy |
|
|||||
|
2025
Q1 | $1.97M | Buy |
|
|||||
|
2024
Q4 | $265K | Buy |
|
|||||
|
2024
Q3 | $392K | Sell |
|
|||||
|
2024
Q2 | $778K | Sell |
|
|||||
|
2024
Q1 | $1.92M | Sell |
|
|||||
|
2023
Q4 | $1.91M | Buy |
|
|||||
|
2023
Q3 | $1.54M | Buy |
|
|||||
|
2023
Q2 | $416K | Buy |
|
|||||
|
2023
Q1 | $403K | Sell |
|
|||||
|
2022
Q4 | $801K | Buy |
|
|||||
|
2022
Q3 | $504K | Buy |
|
|||||
|
2022
Q2 | $354K | Sell |
|
|||||
|
2022
Q1 | $569K | Sell |
|
|||||
|
2021
Q4 | $1.05M | Buy |
|
|||||
|
2021
Q3 | $373K | Sell |
|
|||||
|
2021
Q2 | $351K | Sell |
|
|||||
|
2021
Q1 | $403K | Sell |
|
|||||
|
2020
Q4 | $1.51M | Sell |
|
|||||
|
2020
Q3 | $2.02M | Sell |
|
|||||
|
2020
Q2 | $3.12M | Sell |
|
|||||
|
2020
Q1 | $4.01M | Sell |
|
|||||
|
2019
Q4 | $7.12M | Sell |
|
|||||
|
2019
Q3 | $8.28M | Buy |
|
|||||
|
2019
Q2 | $10.5M | Sell |
|
|||||
|
2019
Q1 | $13.6M | Sell |
|
|||||
|
2018
Q4 | $13.3M | Buy |
|
|||||
|
2018
Q3 | $11.1M | Buy |
|
|||||
|
2018
Q2 | $14M | Sell |
|
|||||
|
2018
Q1 | $10.8M | Sell |
|
|||||
|
2017
Q4 | $9.11M | Sell |
|
|||||
|
2017
Q3 | $7.39M | Buy |
|
|||||
|
2017
Q2 | $4.96M | Buy |
|
|||||
|
2017
Q1 | $3.82M | Buy |
|
|||||
|
2016
Q4 | $3.81M | Buy |
|
|||||
|
2016
Q3 | $2.76M | Buy |
|
|||||
|
2016
Q2 | $1.02M | Buy |
|
|||||
|
2016
Q1 | $1.28M | Sell |
|
|||||
|
2015
Q4 | $1.68M | Sell |
|
|||||
|
2015
Q3 | $1.97M | Buy |
|
|||||
|
2015
Q2 | $2.22M | Buy |
|
|||||
|
2015
Q1 | $1.27M | Sell |
|
|||||
|
2014
Q4 | $3M | Sell |
|
|||||
|
2014
Q3 | $2.34M | Buy |
|
|||||
|
2014
Q2 | $900K | Buy |
|